Skip to Content

SANUWAVE Health Inc SNWV

Morningstar Rating
$0.02 0.00 (9.28%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SNWV is trading at a 140% premium.
Price
$0.02
Fair Value
$7.37
Uncertainty
Extreme
1-Star Price
$5.98
5-Star Price
$8.37
Economic Moat
Pntnb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SNWV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.02
Day Range
$0.020.02
52-Week Range
$0.000.03
Bid/Ask
$0.02 / $0.02
Market Cap
$20.51 Mil
Volume/Avg
232,000 / 385,513

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.69
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
31

Valuation

Metric
SNWV
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.69
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SNWV
Quick Ratio
0.08
Current Ratio
0.15
Interest Coverage
−0.16
Quick Ratio
SNWV

Profitability

Metric
SNWV
Return on Assets (Normalized)
−60.11%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
SNWV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
BxyfdrzzZjhpxvt$184.1 Bil
Stryker Corp
SYK
YfcpnhvxDvmrg$132.0 Bil
Boston Scientific Corp
BSX
TcgnmrnnkNtqtff$113.4 Bil
Medtronic PLC
MDT
RljjdcgRjjwkq$107.5 Bil
Edwards Lifesciences Corp
EW
GhjjhwjxNznpwh$51.9 Bil
DexCom Inc
DXCM
QfthfxvxbMsl$46.2 Bil
Koninklijke Philips NV ADR
PHG
DvrscsghTspyx$24.7 Bil
Zimmer Biomet Holdings Inc
ZBH
XbmqllljwXbgv$22.5 Bil
Steris PLC
STE
QgxtfywtFfsgsq$22.3 Bil
Align Technology Inc
ALGN
FrcsgmkWbkxs$19.1 Bil

Sponsor Center